To ensure access to quality and affordable care for cancer patients within their communities.
The MOASC Vision
Since 1990, MOASC has represented more than 400 oncologists in California and neighboring states. Our association has succeeded in providing value to membership through the creation of the MOASC Purchasing Network (MPN), a GPO for purchasing of drugs and medical office supplies; and the MOASC Contracting Network (MCN) created to represent California medical oncologists in developing new contracting and financial relationships with Payors, promote clinical integration, and enhance the quality, and cost effectiveness, of the medical care provided to cancer patients. MOASC is the source of valuable information for their members through their weekly newsletter the California Oncology Weekly, monthly webinars, meetings, certification courses, and practice management consulting. MOASC strives to continue to succeed in ensuring the continued practice of community oncology care, thereby insuring greater access to oncology treatments for the cancer patient.
Upcoming Events
LunchTime Series Teleconference’s Wednesday, June 26, 2013 at 12:00PM-PST Wednesday, July 31, 2013 at 12:00PM-PST Wednesday, August 28, 2013 at 12:00PM-PST Wednesday, September 25, 2013 at 12:00PM-PST Wednesday, October 30, 2013 at 12:00PM-PST
RSVP via email moasc@moasc.org
Best of ASCO in Los Angeles 8/16/13
Oncology Billing Program
Friday, October 4, 2013 8am -4pm ONS Chemotherapy Certification Program
October 4-5, 2013 8am - 4pm
Both meetings will be held at the Courtyard Marriott in Pasadena.
RSVP to moasc@moasc.org or 1-800-310-3553 ext. 1.
Research-To-Practice Program with Neil Love
Saturday, November 23, 2013 in Los Angeles.
LunchTime Series Teleconference Wednesday, May 29, 2013 at 12:00PM - PST
Topic: Optimizing Your Bottom Line …Migrated Thinking Required Presented by: John Akscin, Founder & Principal Consultant, John Akscin Consulting, LLC In case you missed the presentation, you can listen to the recording by dialing 1-888-203-1112 and enter the pass code 73688358#.
This recording will be available for the next 30 days. Handouts – Click here
TheGeneral Membership Meeting was held Thursday, May 9th in Los Angeles. Click here to view the welcome/synopsis.
Loading........
Industry Meeting with MOASC Board of Directors.
Exhibit Hall & Networking Reception which included Lilly Oncology On Canvas (LOOC) art exhibit. This meeting was sponsored in part by the following companies: ONYX Pharmaceuticals, Pfizer, Spectrum Pharmaceuticals, Merck Oncology, Bristol-Myers Squibb.
Podium presentation by: Robert Vescio, M.D., Cedars-Sinai Medical Center discussing “Overview of KyprolisTM (carfilzomib) for Injection”, sponsored by ONYX Pharmaceuticals.
Dawn Holcombe, MBA, FACMPE, ACHE, President, DGH Consulting discussed The Changing Landscape - Movement Toward Patient Focused Rather Than Provider Focused. (Click here for handouts)
Loading........
As an ASCO State Affiliate, MOASC is excited to announce that it is the first to be highlighted in The ASCO Post . The ASCO Post has begun a new series of articles featuring the successes and advances of ASCO's State Affiliates. The articles will be housed in the "Expert's Corner" section of The ASCO Post.
ASCO invites you to please join them in celebrating their first society to be featured in the series, the Medical Oncology Association of Southern California. For more than 2 decades, the guiding principle of the Medical Oncology Association of Southern California (MOASC) has been to ensure the continuation of the private practice of medical oncology and to provide the highest quality care to cancer patients. Read more about MOASC and their recent success stories online.
Manufacturers may be required to use bar codes on every drug package. In the past six years, there have been 81 deaths, and nearly 800 serious injuries from poisonous Chinese ingredients in heparin, continuous efforts to sell counterfeit Avastin to oncology practices, and numerous instances where fake or stolen versions of atorvastatin (Lipitor) entered the supply chain. Last week, the House of Representatives passed legislation that, by 2015, would require manufacturers to place bar codes on every drug package they ship to track the drug pedigree. The bill doesn't require wholesalers or pharmacies to adopt a computerized tracing system that can make use of those bar codes for another dozen years-and even then only if the Food and Drug Administration comes up with a rule requiring them to do so. The Senate version of the bill requires traceability by wholesalers and pharmacies, but not until 10 years after law enactment. For more information, click here
Thank you to the following sponsors for assisting MOASC in achieving their mission.
